Heim, C., Hartig, L., Weinelt, N., Moser, L. M., Salzmann-Manrique, E., Merker, M., . . . Rettinger, E. Bortezomib promotes the TRAIL-mediated killing of resistant rhabdomyosarcoma by ErbB2/Her2-targeted CAR-NK-92 cells via DR5 upregulation. Elsevier.
Chicago Style (17th ed.) CitationHeim, Catrin, et al. Bortezomib Promotes the TRAIL-mediated Killing of Resistant Rhabdomyosarcoma by ErbB2/Her2-targeted CAR-NK-92 Cells via DR5 Upregulation. Elsevier.
MLA (9th ed.) CitationHeim, Catrin, et al. Bortezomib Promotes the TRAIL-mediated Killing of Resistant Rhabdomyosarcoma by ErbB2/Her2-targeted CAR-NK-92 Cells via DR5 Upregulation. Elsevier.
Warning: These citations may not always be 100% accurate.